Edition:
United Kingdom

Hitachi Chemical Co Ltd (4217.T)

4217.T on Tokyo Stock Exchange

3,295JPY
7:00am BST
Change (% chg)

¥10 (+0.30%)
Prev Close
¥3,285
Open
¥3,285
Day's High
¥3,310
Day's Low
¥3,280
Volume
513,000
Avg. Vol
915,520
52-wk High
¥3,365
52-wk Low
¥1,482

Latest Key Developments (Source: Significant Developments)

Hitachi Chemical To Acquire Apceth Biopharma GmbH
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - Hitachi Chemical Co Ltd <4217.T>::HITACHI CHEMICAL CO. LTD. TO ACQUIRE APCETH BIOPHARMA GMBH, EXPANDING GLOBAL FOOTPRINT OF ITS CELL AND GENE THERAPY CONTRACT DEVELOPMENT AND MANUFACTURING SERVICES.HITACHI CHEMICAL ADVANCED THERAPEUTICS SOLUTIONS - APCETH BIOPHARMA WILL JOIN HITACHI CHEMICAL'S PERCENT GLOBAL SERVICES PLATFORM.  Full Article

SanBio says business alliance with Hitachi Chemical and its unit on manufacturing of SB623
Tuesday, 13 Mar 2018 

March 13 (Reuters) - SanBio Co Ltd <4592.T>:Says co forms business alliance with Hitachi Chemical Co Ltd <<<4217.T>>> and its unit Hitachi Chemical Advanced Therapeutics Solutions, LCC, regarding manufacturing of SB623.  Full Article

Kyowa Hakko Kirin sells 66.6 pct stake in unit Kyowa Medex
Thursday, 4 Jan 2018 

Jan 4(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it sold 66.6 percent stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd <<<4217.T>>>, on Jan. 4 .  Full Article

Kyowa Hakko Kirin to sell part of stake in unit Kyowa Medex
Friday, 29 Sep 2017 

Sept 29(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it will sell a part of stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd.<<<4217.T>>>.Price undetermined .Says the company will cut stake in Kyowa Medex to 33.4 percent .Transaction date on Jan. 4, 2018.  Full Article

Hitachi starts sale of $5.6 billion chemical unit, first bids due by Aug. 9: sources

TOKYO Japan's Hitachi Ltd has started the formal process for the sale of its $5.6 billion chemical unit with initial bids due in August, people familiar with the matter said, a deal that is expected to draw interest from global private-equity firms.